Genesis Drug Discovery & Development, a member of Genesis Biotechnology Group, has acquired New England Discovery Partners (NEDP), a Contract Research Organization specializing in synthetic and medicinal chemistry.
“We’re excited to join the Genesis family of companies, said Michael Van Zandt, President & CEO of NEDP. “In addition to strengthening our supporting services such as human resources and information technologies, we’ll be adding sales and marketing, and making a significant capital investment to expand our Branford facility, particularly in the areas of process chemistry and kilo-scale synthesis. As a result we’ll be a stronger, more vertically integrated company that will be better positioned to serve our clients in New England and across the country.” more